Nutrien (NYSE:NTR) Research Coverage Started at Freedom Broker

Freedom Broker assumed coverage on shares of Nutrien (NYSE:NTR – Free Report) in a research note published on Tuesday, MarketBeat Ratings reports. The brokerage issued a hold rating and a $78.00 price objective on the stock.

Several other equities analysts have also recently weighed in on NTR. Scotiabank upgraded Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price target for the company in a research report on Tuesday, June 30th. Oppenheimer dropped their price objective on Nutrien from $80.00 to $78.00 and set an “outperform” rating on the stock in a report on Thursday, October 22nd. Weiss Ratings downgraded Nutrien from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. UBS Group raised their target price on Nutrien from $59.00 to $62.00 and gave the stock a “sell” rating in a research note on Tuesday. Finally, Morgan Stanley reduced their target price on Nutrien from $93.00 to $81.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Nutrien currently has an average rating of “Moderate Buy” and a consensus price target of $79.24.

View Our Latest Stock Report on NTR

Nutrien Price Performance

NTR opened at $68.51 on Tuesday. The firm has a 50-day moving average price of $73.22 and a 200-day moving average price of $70.93. Nutrien has a twelve month low of $53.03 and a twelve month high of $85.36. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $32.62 billion, a price-to-earnings ratio of 14.76, a PEG ratio of 0.76 and a beta of 0.68.

Nutrien (NYSE:NTR – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The business had revenue of $10.81 billion for the quarter, compared to analysts’ expectations of $10.44 billion. Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.65 earnings per share. Equities analysts expect that Nutrien will post 4.53 EPS for the current year.

Nutrien Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 16th. Investors of record on Tuesday, September 29th were issued a dividend of $0.55 per share. The ex-dividend date of this dividend was Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.2%. Nutrien’s dividend payout ratio (DPR) is currently 44.53%.

Hedge Funds Weigh In On Nutrien

A number of large investors have recently added to or reduced their stakes in NTR. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of Nutrien by 1,014.0% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company’s stock worth $30,000 after buying an additional 436 shares during the period. Global Retirement Partners LLC purchased a new position in Nutrien during the 2nd quarter valued at about $30,000. Evolution Wealth Management Inc. purchased a new position in Nutrien during the 1st quarter valued at about $32,000. Allied Private Wealth LLC purchased a new position in Nutrien during the 2nd quarter valued at about $33,000. Finally, BOK Financial Private Wealth Inc. bought a new stake in Nutrien during the second quarter worth about $51,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Company Profile

(Get Free Report)

Further Reading

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.